Clinical trials of drugs and biopharmaceuticals /
Saved in:
| Imprint: | Boca Raton, FL : CRC Press/Taylor & Francis, 2006. |
|---|---|
| Description: | 500 p. ; 27 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/5871809 |
Table of Contents:
- Pt. I. Preparation for clinical trials
- Ch. 1. Drug discovery and preclinical research / Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu and Benjamin R. Lee
- Ch. 2. The pharmaceutical background / Shri C. Valvani
- Ch. 3. The pharmacological background for drug evaluation / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Ch. 4. Animal tests as predictors of human response / Peter I. Folb
- Pt. II. Regulatory organization and decision making
- Ch. 5. Worldwide regulatory agencies / Christopher L. Wu, Benjamin R. Lee and Mei-Ling Chen
- Ch. 6. Decision points in drug development / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Ch. 7. Management of clinical development costs / Mark Hovde
- Ch. 8. Ethical aspects and good clinical practice / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Ch. 9. Investigational new drug application and the licensure approval process / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Ch. 10. Clinical trials from phase I to phase IV / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Pt. III. Evaluation and quality assurance of drugs and biopharmaceuticals
- Ch. 11. The assessment of pharmacokinetics in early-phase drug evaluation / Paul E. Rolan and Valeria Molnar
- Ch. 12. Drug interactions / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Pt. IV. Assessment of cardiovascular drugs
- Ch. 13. Antianginal drugs / Nancy C. Pauly and Edmond Roland
- Ch. 14. Antihypertensive drugs / W. Stephen Waring and David J. Webb
- Ch. 15. Drugs for treatment of stroke / Mariola Soehngen, Wolfgang Soehngen and Yasir Al-Rawi
- Pt. V. Assessment of respiratory drugs
- Ch. 16. Antiasthmatic drugs / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Pt. VI. Assessment of central nervous system drugs
- Ch. 17. Anxiolytics and hypnotics / Graham R. McClelland and Georges Moroz
- Ch. 18. Antidepressants / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Ch. 19. Drugs for Alzheimer's disease and other dementias / Benjamin R. Lee, Lucia H. Lee, Christopher L. Wu and Chi-Jen Lee
- Pt. VII. Assessment of gastrointestinal and liver drugs
- Ch. 20. Antiulcer drugs / Benjamin R. Lee, Lucia H. Lee, Christopher L. Wu and Chi-Jen Lee
- Pt. VIII. Assessment of genitourinary drugs
- Ch. 21. Diuretics / Hitesh H. Shah, Pravin C. Singhal and Joseph Mattana
- Ch. 22. Medical therapy of benign prostatic hyperplasia / Benjamin R. Lee
- Pt. IX. Assessment of skin drugs
- Ch. 23. Drugs for the treatment of specific skin diseases / Muzlifah A. Haniffa, Anton B. Alexandroff Vrach, Suzy N. Leech and Clifford M. Lawrence
- Ch. 24. Drugs for the treatment of atopic eczema / Christopher L. Wu, Lucia H. Lee, Benjamin R. Lee and Chi-Jen Lee
- Pt. X. Assessment of metabolism drugs
- Ch. 25. Drugs for treatment of disorders of lipid metabolism / Christopher L. Wu, Lucia H. Lee, Benjamin R. Lee and Chi-Jen Lee
- Ch. 26. Antidiabetic drugs / Christopher L. Wu, Lucia H. Lee, Benjamin R. Lee and Chi-Jen Lee
- Pt. XI. Assessment of chemotherapeutic drugs
- Ch. 27. Antibiotics / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Ch. 28. Antiviral drugs / Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee and Chi-Jen Lee
- Ch. 29. Anticancer drugs / Robert E. Martell, Christiane Langer and Renzo Canetta
- Pt. XII. Assessment of antiinflammatory and pain drugs
- Ch. 30. Analgesics / Christopher L. Wu, Robert W. Hurley and Joseph W. Stauffer
- Pt. XIII. Assessment of biopharmaceuticals
- Ch. 31. Vaccines / Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu and Benjamin R. Lee
- Ch. 32. Herbal products as complementary and alternative medicine / Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu and Benjamin R. Lee
- Ch. 33. Biotechnology-derived pharmaceuticals / Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu and Benjamin R. Lee
- Pt. XIV. Future perspective
- Ch. 34. Future perspectives in drug development / Christopher L. Wu, Benjamin R. Lee and Mei-Ling Chen
- Ch. 35. Future perspectives in biopharmaceutical development / Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu and Benjamin R. Lee.
